Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Explore value comparisons for travel points redemptions to make informed choices. Get the most out of your rewards.
22,567 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Brookstone Capital's 13F reveals a modest stake in the XRP ETF, but viral posts claim a $71 million position due to a...
Oil States International (OIS) faces a shifting offshore market as 2025 unfolds. This guide breaks down the likely dr...
Brace yourself for a clear, investor-friendly read on chord energy (chrd) 2025 Q4 results. This deep dive breaks down...
A fashion brand founder downsizes a high-revenue operation to pursue profitability, exemplifying a growing trend amon...
Investors are watching limoneira (lmnr) 2026 earnings for clues on citrus demand, real estate activity, and cost mana...
Bitcoin has fallen out of step with broad money growth, creating a large gap between its price and M2-derived fair va...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...
An investor's guide to the early signals from hims 2026 earnings. We break down Q1 results, margins, and what they me...
NextEra Energy is pursuing a $67 billion all-stock deal to buy Dominion, aiming to create the world’s largest utility...
A spike in revenue can grab headlines, but it rarely tells the full investment story. Here’s why super micro computer...
As the clean energy shift accelerates, two hydrogen-focused leaders—Bloom Energy and Plug Power—offer distinct paths ...